Stock Market: Selling Shares Becomes Cheaper Than Issuing Debt

For the better part of a decade, Bryan Riggsbee did what countless other finance chiefs, both in the US and beyond, had done when their companies needed money — he borrowed it.

Late last year, the chief financial officer at Myriad Genetics Inc. took a different tack, one the DNA-testing company hadn’t seriously considered in over 16 years — selling shares.